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Mycobacterium tuberculosis utilizes unique strategies to
survive amid the hostile environment of infected host cells.
Infection-specific expression of a unique mycobacterial cell
surface antigen that could modulate key signaling cascades
can act as a key survival strategy in curtailing host effector
responses like oxidative stress. We demonstrate here that
hypothetical PE_PGRS11 ORF encodes a functional phospho-
glycerate mutase. The transcriptional analysis revealed that
PE_PGRS11 is a hypoxia-responsive gene, and enforced expres-
sion of PE_PGRS11 by recombinant adenovirus or Mycobacte-
rium smegmatis imparted resistance to alveolar epithelial cells
against oxidative stress. PE_PGRS11-induced resistance to oxi-
dative stress necessitated the modulation of genetic signatures
like induced expression of Bcl2 or COX-2. This modulation of
specific antiapoptotic molecular signatures involved recogni-
tion of PE_PGRS11 by TLR2 and subsequent activation of the
PI3K-ERK1/2-NF-B signaling axis. Furthermore, PE_PGRS11
markedly diminished H2O2-induced p38 MAPK activation.
Interestingly, PE_PGRS11 protein was exposed at themycobac-
terial cell surface and was involved in survival of mycobacteria
under oxidative stress. Furthermore, PE_PGRS11 displayed dif-
ferential B cell responses during tuberculosis infection. Taken
together, our investigation identified PE_PGRS11 as an in vivo
expressed immunodominant antigen that plays a crucial role in
modulating cellular life span restrictions imposed during oxida-
tive stress by triggering TLR2-dependent expression of COX-2
andBcl2. These observations clearly provide amechanistic basis
for the rescue of pathogenicMycobacterium-infected lung epi-
thelial cells from oxidative stress.
Mycobacterium tuberculosis exhibits diverse clever strategies
to survive inside the hostile environment of host cells (1). The
variable efficacy of Mycobacterium bovis bacillus Calmette-
Gue´rin vaccine, emergence of multidrug-resistant and exten-
sively drug-resistant strains, and coinfection of HIV andmyco-
bacteria in patients have culminated in the immediate need to
identify unique targets as well as develop new therapeutic inter-
vention strategies for tuberculosis disease (2, 3). In this perspec-
tive, functional characterization of enzymes or antigenic pro-
teins that possess enzymatic domains catalyzing important
metabolic functions assumes critical importance. In this regard,
current study attempts to understandmolecular details on how
cell wall-associated proline-glutamic acid (PE)3 family mem-
bers of M. tuberculosis could modulate host cellular pathways
and their functions, which could impart survival amid hostile
host effector functions such as oxidative stress. PE antigens
along with proline-proline-glutamic acid (PPE) represent 10%
of the coding capacity of the M. tuberculosis genome and are
characterized by a conserved PE or PPE domain near the N
terminus with substantial variation in the C terminus of the
antigens (4, 5). Besides being uniquely restricted tomycobacte-
ria, PE family proteins are suggested to have critical roles in the
pathogenesis of tuberculosis and in modulation of host innate
and adaptive immunity (6–9). Expression profiling studies have
demonstrated infection-specific expression of several PE genes
in host cells, and polymorphism in the C-terminal PGRS region
has been implicated in antigenic variation with subsequent
roles in evasion from recognition by host immunity (10, 11). A
significant number of PE_PGRS antigens associate with the cell
wall and are exposed on the surface of the bacterium; thus,
they are effectively trafficked out from the phagolysosomal
platform into intracellular compartments as well as to the
extracellular milieu (10, 12, 13). Nevertheless, precise patho-
physiological attributes of PE_PGRS antigens remain the focus
of extensive research. In the current study, we demonstrate that
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PE_PGRS11 (Rv0754), a prototype hypothetical PE_PGRS anti-
gen, is a hypoxia-responsive gene and encodes a functional
phosphoglycerate mutase. Enforced expression of PE_PGRS11
by a replication-deficient recombinant adenovirus or recombi-
nantMycobacterium smegmatis imparted resistance to alveolar
epithelial cells against H2O2-induced oxidative stress.
PE_PGRS11-induced resistance to oxidative stress involved
extensive participation and signaling cross-talk among mem-
bers of the phosphoinositide 3-kinase (PI3K)-ERK1/2-NF-B
signaling axis. The PE_PGRS11-induced signaling required
Toll-like receptor 2 (TLR2), which culminates in the expression
of cyclooxygenase-2 (COX-2) and Bcl2. Importantly, in addi-
tion to its in vivo expression during infection, mycobacterial
cell surface association of PE_PGRS11 played a novel role in
survival of mycobacteria under oxidative stress. These results
implicate PE_PGRS11 as an immunodominant antigen that
plays a crucial role in modulating alveolar epithelial cell fate
decisions under oxidative stress.
EXPERIMENTAL PROCEDURES
Cell Line and Bacterial Culture—The human type II alveolar
epithelial cell line A549 (obtained from the National Centre for
Cell Sciences, Pune, India) was cultivated in DMEM supple-
mented with 10% heat-inactivated FBS (Sigma-Aldrich). M.
bovis BCG 1173P2was grown tomid-log phase inMiddlebrook
7H9 plus albumin-, dextrose-, and catalase-supplemented
medium. Batch cultures were aliquoted and stored at 70 °C.
Representative vials were thawed and enumerated for viable
colony-forming units (cfu) on Middlebrook 7H10 agar (Difco)
supplemented with oleic acid, albumin, dextrose, and catalase.
Single cell suspensions of mycobacteria were obtained by short
pulses of sonication (Sonics). M. smegmatis mc2155 was cul-
tured in Middlebrook 7H10 agar (Difco) supplemented with
oleic acid, albumin, dextrose, and catalase.
Reagents and Antibodies—General laboratory chemicals
were purchased from Sigma-Aldrich or Merck. The anti-Ser65
phospho-4EBP1, anti-4EBP1, anti-Thr180/Tyr182 phospho-p38
MAPK, anti-p38 MAPK, anti-Thr202/Tyr204 phospho-ERK1/2,
anti-ERK1/2, anti-phospho-Tyr458/Tyr199 p85, anti-p85, and
anti-NF-B p65 were purchased from Cell Signaling Technol-
ogy. Anti-Bcl2 was obtained from Santa Cruz Biotechnology.
Anti--actin antibody (AC-15) and anti-PGE2 were procured
from Sigma-Aldrich. Anti-COX-2 and anti-proliferating cell
nuclear antigen were obtained from Calbiochem.
Cloning, Mutagenesis, Expression, and Purification of
PE_PGRS11—The PE_PGRS11 gene was PCR-amplified from
M. tuberculosisH37Rv genomicDNAusing the following gene-
specific primers: 5-CGGGATCCATGTCATTTGTGATCG-
TGGCG-3 (forward) and 5-CCCAAGCTTTCATGGGATC-
AGGCTGGGCAG-3 (reverse). The amplified PCR product
was ligated into the pGEMT-Easy vector (Promega), and the
recombinant clones carrying the PE_PGRS11 gene insert were
confirmed by DNA sequencing. The PE_PGRS11 gene insert
from pGEMT-Easy vector was subcloned into pRSETA vector
(Invitrogen) to generate pRSETA-PE_PGRS11 for protein
expression and purification. The phosphoglycerate mutase
domain of PE_PGRS11 was PCR-amplified from pRSETA-
PE_PGRS11 plasmid using domain-specific primers, 5-CGC-
GGATCCATGCAGATCGTCATC-3 (forward) and 5-CCC-
AAGCTTTCACGGATGGGGGTCGAC-3 (reverse), followed
by ligation into pGEMT-Easy vector and further subclon-
ing into pRSETA vector. Putative active site mutants of
PE_PGRS11 protein were generated by site-directed mutagen-
esis using the megaprimer inverse PCR method. The forward
primer comprised the desired mutation, and respective reverse
primers were used to generate the megaprimer. The mega-
primer was used in turn to amplify the entire plasmid. The
sequences of the primers (forward and reverse) used to incor-
porate mutations spanning the residues R289A, H290A,
G291A, and S348A in the putative ligand binding motif of
PE_PGRS11 are illustrated in supplemental Fig. S1. All the
mutations were confirmed by DNA sequence analysis. Further-
more, Escherichia coli BL21 cells carrying the appropriate recom-
binant plasmid were induced with isopropyl -D-thiogalactopyr-
anoside, and His-tagged recombinant proteins were purified with
a nickel-nitrilotriacetic acid column (Qiagen).
Generation of Polyclonal Antibodies to PE_PGRS11—The
polyclonal antibodies against PE_PGRS11 were generated in
rabbits by subcutaneous injection of 1 mg of purified protein
emulsified with an equal volume of Freund’s adjuvant (Sigma-
Aldrich). The first immunization was followed by two booster
immunizations with Freund’s incomplete adjuvant at 21-day
intervals. The antibody titers in the serum were determined by
ELISA 2 weeks after final immunization.
Sequence Comparisons and Model Building—Sequence sim-
ilarity searches were carried out using BLAST, PSI-BLAST, and
FASTA against the NCBI non-redundant database and Protein
Data Bank. The PE_PGRS11 sequence was scanned against
Conserved Domains Database to identify any known domains.
The structure of the domain thus identifiedwas built by homol-
ogymodeling usingModeler. To understand the importance of
different regions in the template structure, structural homo-
logues of the chosen template (Protein Data Bank code 1C81)
were identified through Dali searches. Structurally conserved
regions among the homologues were identified and used as
restraints on the target, as implemented inModeler, by express-
ing them as probability density functions. The initial models
that satisfied these along with the stereochemical restraints
were optimized by a combination of conjugate gradients and
molecular dynamics with simulated annealing. The stereo-
chemical quality of the model was validated using PROCHECK
andWHATIF.
Ligand Docking—Conserved active site residues in the target
sequence were identified by aligning it with homologous
sequenceswith known structures using the sequence annotated
by structure tool. Probable active site pockets were identified
independently by various geometric methods using the mod-
eled structure with the help of CASTp, Molecular Operating
Environment, and the Site Finder module in Insight II. The
chosen ligand 3-phosphoglyceric acid was docked into the tar-
get structure using AutoDock to test the possibility of binding
and the precise location of binding sites. The possible binding
conformations and orientations were also analyzed by cluster-
ing methods embedded in AutoDock. To address the issue of
protein flexibility and any conformational fine tuning of the
active site residues, upon ligand binding, a postdocking energy
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minimizationwas carried out using theDiscover suite by allow-
ing full freedom to all the atoms of the protein and ligand. The
protein-drug interactions such as hydrogen bonding, hydro-
phobic interactions, and aromatic stacking were evaluated
using Ligand-Protein Contacts software. As a control exercise,
the same ligand was stripped out of the original Protein Data
Bank file and docked back into the template structure using an
identical protocol and parameter set. The Accelrys software
package (Insight II modules, Accelrys Inc.) was used to visual-
ize, analyze, and manipulate the structures.
Estimation of Enzymatic Activity of PhosphoglycerateMutase
Domain of PE_PGRS11—Phosphoglycerate mutase activity of
PE_PGRS11 was assayed by coupling the reaction to enolase as
described previously (14, 15). Briefly, the conversion of 3-phos-
phoglyceric acid to 2-phosphoglyceric acid was determined by
estimating NADH oxidation at 340 nm in an assay mixture
containing 79 mM triethanolamine, pH 7.6, 6.6 mM D-()-3-
phosphoglyceric acid, 0.70 mM adenosine 5-diphosphate, 1.3
mM 2,3-diphospho-D-glyceric acid, 0.15 mM -NADH, 2.5 mM
MgSO4, 99 mM KCl, 14 units of pyruvate kinase, 20 units of
L-lactic acid dehydrogenase, 3 units of enolase, and 0.03–0.06
unit of PE_PGRS11 purified protein.
Establishment of M. tuberculosis H37Ra Dormant Cultures
Using Wayne’s Model for Dormancy—M. tuberculosis H37Ra
dormant cultures were established as described previously (16).
In brief, 40 ml of albumin, dextrose, and catalase supplement
was added to 360ml of sterile Dubos broth base containing 500
g/mlmethylene blue as an oxygen depletion indicator (Difco).
Themediumwas inoculatedwith a preinoculumhaving anA600
of 0.6, and the culture was incubated at 37 °C with agitation at
130 rpm. On the 12th day, the culture was harvested after
reaching the stage of non-replicating persistence, washed with
Tween-saline (0.8% (w/v) NaCl and 0.05% (v/v) Tween 80) and
processed for RNA isolation.
Establishment of Nutrient-depleted Stationary Phase Growth
Condition for M. tuberculosis H37Ra—For generating the
nutrient-starved stationary phase culture, M. tuberculosis
H37Ra cells were grown in a rotatory shaker at 37 °C until A600
reached 2.5 (15 days) followed by standing, non-shaking con-
dition at 37 °C for another 30 days for gradual depletion of
nutrients and microaerophilic submerged growth. After 30
days, bacteria were harvested, washed with Tween-saline, and
processed for the isolation of total RNA.
Isolation of RNA fromM. tuberculosis H37Ra and Quantita-
tive Real Time PCR for PE_PGRS11—Total RNA was extracted
from M. tuberculosis H37Ra cells using a well established hot
phenol method (17) with slight modifications. In brief, har-
vested cells were lysed in 30 mM Tris-HCl, pH 7.4 containing
100 mMNaCl, 5 mM EDTA, 1% SDS, and 5mM vanadyl ribonu-
cleoside complex by sonication. The sonication conditions
included four pulses of 10-s duration at 50% duty cycle. Lysates
were incubated on ice for 10 min and then extracted with 65 °C
preheated phenol (saturated with 100 mM sodium acetate
buffer, pH 5.2, containing 10 mM EDTA), phenol chloroform,
and chloroform, twice each. Total RNA was precipitated using
0.3 M sodium acetate and an equal volume of isopropanol and
was finally dissolved in RNase-freewater. 1g of total RNAwas
reverse transcribed to cDNA using a first strand cDNA synthesis
kit (MBI Fermentas) according to the manufacturer’s instruc-
tions. A real time PCR amplification (Applied Biosystems)
using SYBR Green PCR mixture (Finnzymes) was performed
for quantification of PE_PGRS11, narG, and HspX. Amplifica-
tion of 16 S rRNA was used as an internal control. The forward
and reverse primer pairs used were as follows: PE_PGRS11
forward, 5-ATCGTCATCGACTTCGTGCG-3; PE_PGRS11
reverse, 5-GGTCTGCTGCGTTCTGATCAAC-3; HspX
forward, 5-ATGGCCACCACCCTTCCCGTTC-3; HspX
reverse, 5-GACCATCGCGGACCATAATGTCGAC-3; narG
forward, 5-ACTACGCCGACAACACCAAGTTCGCCGACG-
3; narG reverse, 5-AGCGGCGCACATAGTCGACAAAGA-
ACGGAA-3; 16 S rRNA forward, 5-GCACCGGCCAACTA-
CGTG-3, and 16 S rRNA reverse, 5-GAACAACGC-
GACAAACCACC-3.
Construction of Recombinant Adenovirus Expressing PE_
PGRS11—Replication-deficient recombinant adenovirus ex-
pressing PE_PGRS11 was generated according to the protocol
as described (18). Briefly, PE_PGRS11 was subcloned into
pAdTrack-CMV vector after releasing the gene insert from
pGEMT Easy-PE_PGRS11. PmeI-linearized pAdTrack-CMV-
PE_PGRS11 was co-electroporated with pAdEasy-1 vector,
which contains the adenoviral genome backbone except E1 and
E3proteins, intoE. coliBJ5183 strain. The cloneswere screened
for recombinants by confirmative restriction digestions.
Recombinant adenoviral DNA was digested with PacI and
transfected into HEK-293 cells. HEK-293 cells stably express
E1and E3 proteins and help in generation and replication of
recombinant adenovirus. The appearance of cells expressing
green fluorescent protein (GFP) and clearing zones indicates
the generation of recombinant adenovirus. Expression of
PE_PGRS11 was established by immunoblotting as well as
immunocytochemistry. After 7 days of transfection, cell lysate
was prepared by repeated freezing and thawing followed by
fresh infection of HEK-293 cells with the lysate to get high titer
virus. The resultant viruses were purified by CsCl banding as
described previously (19). Briefly, cell-free viral supernatants
were prepared by centrifugation at 3000  g for 10 min. The
concentrated viral supernatant was subjected to CsCl ultracen-
trifugation to separate the viruses from the cellular proteins and
medium components. Following ultracentrifugation, CsCl was
removed by dialysis, and viral titers were calculated. For infec-
tion of A549 cells, 2  103 cells/well were seeded in 96-well
culture plates followed by infection with recombinant adenovi-
rus at a multiplicity of infection of 10 at 37 °C in normal growth
medium.
Generation of Recombinant M. smegmatis Expressing PE_
PGRS11—For generation of recombinant M. smegmatis over-
expressing PE_PGRS11, PE_PGRS11 was subcloned into
pJAM2 vector, which is an M. smegmatis and E. coli shuttle
vector with an acetamide-inducible expression system. The
PE_PGRS11 gene insert was released from pGEMT Easy-
PE_PGRS11 with BamHI and XbaI restriction endonucleases
and mobilized into pJAM2. M. smegmatis underwent electro-
porationwith pJAM2-PE_PGRS11 to generate recombinantM.
smegmatis followed by induction with acetamide to induce the
expression of PE_PGRS11, which was further confirmed by
PE_PGRS11 Protein Imparts Resistance to Oxidative Stress
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immunoblotting. Similarly, M. smegmatis was transformed
with pJAM2 vector to generate control transformants.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bro-
mide (MTT) Assay—Assessment of cellular proliferation by
MTT assay was carried out as described previously (20). Briefly,
1.5 103 A549 cells/well were seeded in a 96-well plate. After
12 h of plating, the cells were treated as indicated followed by
addition of MTT (20 l of 5 mg/ml) 3 h prior to completion of
the experiment. MTT is a tetrazolium salt that is converted by
living cells into blue formazan crystals. The cell-free superna-
tant was removed from thewells 3 h afterMTT addition, 200l
of DMSO was added to dissolve the formazan crystal, and the
absorbance was measured at 550 nm in an ELISA reader
(Molecular Devices).
Treatment of A549 Cells with Pharmacological Inhibitors of
Signaling Pathways—All the pharmacological inhibitors were
obtained from Calbiochem. They were reconstituted in sterile,
cell culture grade DMSO (Sigma-Aldrich) and used at the fol-
lowing concentrations after determining the viability of A549
cells in titration experiments using the MTT assay: U0126, 10
M, LY294002, 50M, AKT inhibitor II, 10M, and NS-398, 20
M. DMSO at 0.1% concentration was used as the vehicle
control.
Immunoblotting Analysis—For immunoblot analysis, A549
cells were grown in 60-mm culture dishes and treated as indi-
cated. Cells were washed twice with phosphate-buffered saline
(PBS); lysed in modified radioimmune precipitation assay
buffer (Upstate Biotechnology) consisting of 50 mM Tris-HCl,
pH 7.4, 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM
NaCl, 1 mM EDTA, 1 mM PMSF, 1 g/ml aprotinin, 1 g/ml
leupeptin, 1 g/ml pepstatin, 1 mM Na3VO4, and 1 mM NaF;
and incubated at 4 °C for 30 min. Cell lysates were collected
after centrifugation at 13,000 g for 10min. The immunoblot-
ting for the intended protein was carried out according to the
protocol described elsewhere (21). Briefly, protein lysates were
subjected to SDS-PAGE and transferred onto PVDF mem-
branes (Millipore) by a semidry Western blotting (Bio-Rad)
apparatus. Nonspecific bindingwas blockedwith 5% nonfat dry
milk powder in TBST (20 mM Tris-HCl, pH 7.4, 137 mM NaCl,
and 0.1% Tween 20) for 60min. The blots were incubated over-
night at 4 °C or for 2 h at room temperature with primary anti-
bodies diluted in TBST with 5% BSA. The primary antibody
dilutions were made according to the manufacturer’s instruc-
tions. After washing with TBST, blots were incubated with goat
anti-rabbit or anti-mouse IgG secondary antibody conjugated
to HRP (Jackson ImmunoResearch Laboratories) diluted in
TBST for 2 h. After further rinsing in TBST, the immunoblots
were developed with the ECL system (PerkinElmer Life Sci-
ences) following the manufacturer’s instructions.
Nuclear and Cytosolic Subcellular Fractionation—A549 cells
were washed with ice-cold PBS and gently resuspended in ice-
cold Buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM
EDTA, 0.1 mM EGTA, 1 mM DTT, and 0.5 mM PMSF). After
incubation on ice for 15 min, cell membranes were disrupted
with 10% Nonidet P-40, and the nuclear pellets were recovered
by centrifugation at 13,000  g for 15 min at 4 °C. The super-
natants from this step were used as cytosolic extracts. Nuclear
pellets were lysedwith ice-cold Buffer C (20mMHEPES, pH7.9,
0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and 1 mM
PMSF), and nuclear extracts were collected after centrifugation
at 13,000 g for 20 min at 4 °C.
Transient Transfections and Immunofluorescence—
HEK-293 cells were transiently transfected with TLR2 overex-
pression and NF-B-luciferase reporter constructs using
ESCORT III (Sigma-Aldrich). For immunofluorescence stud-
ies, vector or TLR2 cDNA construct-transfectedHEK-293 cells
were seeded in a 35-mm dish on coverslips and treated with 2
g/ml purified PE_PGRS11 protein for 1 h. Cells were fixed
with cold methanol for 15 min and stained with anti-
PE_PGRS11 antibodies for 1 h followed by incubation with sec-
ondary antibody (Cy5-conjugated anti-rabbit IgG) in the dark
for 1 h at room temperature. Coverslips with cells were
mounted on a slide with Fluoromount-G, and immunofluores-
cence images were acquired by a Zeiss LSM 510Meta confocal
laser scanning microscope. The images were analyzed for the
integrated density of the fluorescence and for the area of the
cells using Zeiss LSM image browser software.
Luciferase Assay—HEK-293 cells transfected with TLR2
cDNA and NF-B-luciferase reporter constructs were treated
with purified PE_PGRS11 for 12 h. Cells were lysed in reporter
lysis buffer (Promega), and luciferase activity was assayed using
luciferase assay reagent (Promega). The results were normal-
ized for transfection efficiencies by assay of -galactosidase
activity.
Preparation of Subcellular Fractions ofMycobacterium—The
subcellular fractionation was carried out according to the pro-
tocol described previously (22, 23). Briefly, the cells were lysed
by sonication in breaking buffer (PBS, pH 7.4 with 1mMEDTA,
1 g/ml pepstatin, 1 g/ml leupeptin, 200 M PMSF, and 100
mMTris-HCl, pH 8.0). Cell debris were removed by centrifuga-
tion at 3000 g for 5min, and the supernatant was subjected to
ultracentrifugation at 27,000 g for 1 h at 4 °C. The pellet from
this centrifugation step was considered the cell wall fraction
and was resuspended in breaking buffer. The supernatant con-
taining the membrane and cytosol fractions was again sub-
jected to centrifugation at 100,000  g for 4 h at 4 °C, and this
step was repeated with supernatant obtained in the earlier step.
The supernatant fraction from both steps was considered as
the cytosol fraction, whereas the pellets were considered as the
membrane fraction. All the fractions were quantified for the
amount of protein by the Bradford method and subjected to
immunoblotting for analysis of PE_PGRS11 expression.
Proteinase K and Trypsin Sensitivity Assays—M. smegmatis
harboring vector or pJAM2-PE_PGRS11 were induced with 2%
acetamide for 6 h and harvested. Cells werewashed once inTBS
buffer (20 nM Tris-HCl, pH 7.5, 150 mM NaCl, and 3 mM KCl)
and resuspended in 1 ml of the same buffer. Each sample was
divided into two identical aliquots; onewasmixedwith protein-
ase K (MBI Fermentas) and one was mixed proteinase K (MBI
Fermentas), with trypsin (Amresco) up to a concentration of
100g/ml. Both aliquots were incubated for the indicated time
points at 37 °C. The reaction was stopped by adding 200 nM
PMSF and 1 g/ml aprotinin. Samples were centrifuged, and
the pellet was washed three times in TBS and dissolved in SDS
sample buffer (30% (v/v) glycerol, 10% (w/v) SDS, 312mMTris-
HCl, pH 6.8, 0.25% (w/v) bromphenol blue, 0.25% (w/v) xylene
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cyanol, and 5% (v/v) -mercaptoethanol) followed by analysis
of PE_PGRS11 integrity by immunoblotting.
Patients and Control Subjects—The study population for
serological characterization (n 211) was comprised of tuber-
culosis (TB) bacillus-infected patients reporting to theNational
Jalma Institute of Leprosy andOtherMycobacterial Diseases in
Agra, India. The patient populationwas categorized into differ-
ent clinical groups as follows. Group 1 (n  94) patients were
diagnosed with pulmonary TB for the first time and had no
history of chemotherapeutic treatment. Group 1 included 69
adults and 25 children. Group 2 (n  30) patients exhibited
relapsed infection, and all enlisted patients were adults. Group
3 (n  31) patients, diagnosed with extrapulmonary TB infec-
tions, included nine adults and 22 children. The patients were
categorized according to guidelines of the National TB Control
Program, Central TB Division, Government of India. The diag-
nosis of pulmonary tuberculosis in group 1 and 2 patients was
established based on clinical and radiological data togetherwith
the identification of acid-fast bacilli in sputum. In the case of
group 2 patients with relapsed infection, the patients were diag-
nosed with pulmonary TB, but after a full course of antituber-
cular chemotherapeutic treatment, these patients had a recur-
rence of the infection and disease symptoms. Group 3 patients
were primarily diagnosed with abdominal TB infection or
tuberculosis meningitis (TBM). The diagnosis of extrapulmo-
nary TB was confirmed by histological examination as well as
with culture positivity of the bacillus in specimens obtained
from extrapulmonary sites. The age ranges of adults and chil-
dren were 18–60 and 2–15 years, respectively. The healthy
donors (n  56) were negative for active tuberculosis disease.
Additionally, healthy donors included in the study were age-
and gender-matched to the different clinical groups. The sam-
ples from HIV-positive subjects were excluded from the study.
Cerebrospinal fluid (CSF) samples (n  73) were collected
from patients reporting to the National Institute of Mental
Health and Neuro Sciences, Bangalore, India. The diagnosis of
TBM was established by detection of acid-fast bacilli in CSF of
patients. Other disease control samples (n 18) included other
meningitis diseases like pyogenic meningitis, viral meningitis,
etc. Healthy controls (n  12) included cases of death by acci-
dent or meningitis-suspected cases but proven to be clinically
healthy. The samples from HIV-positive subjects were not
included in the study. The samples were collected without gen-
der or age bias. All the included subjects for both serum and
CSF characterization had given written consent, and the cur-
rent study was carried out after approval from the institutional
bioethics committee.
Serological Characterization of PE_PGRS11—ELISAs were
carried out in 96-well microtiter plates (Nunc). ELISA plates
were incubated with purified recombinant PE_PGRS11 protein
overnight at 4 °C followed by three washes with PBS-Tween 20
(0.05%) buffer. After blocking with 3% BSA in PBS for 1 h at
37 °C, wells were incubated with human serum (1:400 dilution
in blocking buffer) or CSF samples (1:10) for 1 h at 37 °C fol-
lowed by washing with PBS-Tween 20 buffer. The plates were
further incubated with HRP-labeled anti-human IgG or IgM
secondary antibody for 1 h at 37 °C followed by development
with o-phenylenediamine tetrahydrochloride. The absorbance
valuesweremeasured at 492 nmusing an ELISA reader (Molec-
ular Devices).
Zone of Inhibition Assay—The zone of inhibition or disc dif-
fusion assay was performed as described previously (24). In
brief, culture plates were inoculated with M. smegmatis trans-
formed with pJAM2 and pJAM2-PE_PGRS11 by wiping with
sterile cotton swabs dipped in the respective cultures. Then
sterile filter disks dipped in H2O2 (30%) were placed on culture
plates followed by incubation of the plates at 37 °C for 24 h.
After 24 h, the diameter of the zone of inhibition around each
disk was measured.
Statistical Analysis—Levels of significance for comparison
between samples were determined by Student’s t test distribu-
tion. The data in the graphs are expressed as themean S.D. or
S.E. GraphPad Prism 3.0 software (GraphPad software) was
used for all statistical analysis. Comparisons of immunoreactiv-
itieswithin clinical groupswere carried out using one-way anal-
ysis of variance followed by Bonferroni’s multiple comparison
test.
RESULTS
Hypothetical PE_PGRS ORF Encodes a Functional Phospho-
glycerateMutase—Studies have advocated that themembers of
PE_PGRS family proteins including hypothetical PE_PGRS11
protein could have critical roles in the pathogenesis of tubercu-
losis as well as in modulating host innate and adaptive immune
responses to pathogenic mycobacteria (8, 9). In view of these
observations, initial bioinformatics analysis of PE_PGRS11 was
performed as described to identify domains of importance, and
in this regard, a search against the domain database showed
the presence of the phosphoglycerate mutase domain. The
phosphoglycerate mutase domain of PE_PGRS11 exhibited
significant sequence similarity to phosphoglycerate mutases
characterized across diverse organisms with the core phospho-
glycerate mutase domain containing critical catalytic residues
required for enzymatic activity (Fig. 1A). Secondary structure
prediction, homology domain modeling, and ligand docking
studies were carried out to ascertain the phosphoglycerate
mutase domain of PE_PGRS11 (Fig. 1A). Because this is the first
report of a PE_PGRS antigen possessing a functional phospho-
glycerate mutase domain, the current study characterized
PE_PGRS11 in terms of its biochemical and functional proper-
ties in greater detail.
Catalytic Properties of Phosphoglycerate Mutase Domain of
PE_PGRS11—The gene encoding PE_PGRS11was PCR-ampli-
fied, cloned, and heterologously overexpressed in E. coli strain
BL21(DE3) pLysS as a His-tagged protein. The recombinant
PE_PGRS11 protein with mobility corresponding to 57 kDa,
which is the same as the calculated theoretical molecular mass,
was induced with isopropyl 1-thio--D-galactopyranoside. The
PE_PGRS11 protein was purified to homogeneity (supple-
mental Fig. S2A) and was utilized to characterize the phospho-
glycerate mutase enzymatic activity as well as to generate
polyclonal antibodies. Upon analysis of kinetic properties,
recombinant PE_PGRS11 protein exhibitedMichaelis-Menten
kinetics as Km and Vmax for the enzyme were calculated as 1.82
mM and 2.645 M/min, respectively (Fig. 1B). The substrate
saturation curves were hyperbolic for the phosphoglycerate
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mutase enzyme, and the effects of pH or metal ions on enzyme
kinetics were also studied. The pH plays a critical role in deter-
mining the enzymatic activity of phosphoglycerate mutase.
Phosphoglycerate mutase of PE_PGRS11 was found to be
broadly active between pH 6 and 9 with a pH optimum of 7.5
(supplemental Fig. S2B). The pH optimum is similar to that of
diverse eukaryotic as well as bacterial phosphoglycerate muta-
ses (25, 26). For example, phosphoglyceratemutase from rabbit
muscle demonstrated a pH optimum of 7, whereas purified
enzyme from Hyphomicrobium exhibited maximum catalytic
activity at pH 7.3. Similarly, phosphoglycerate mutase from
Pseudomonas exhibited maximum activity over the pH range
7.0–7.6. Metal ions like Mg2 can act as essential cofactors for
most of the enzymes that catalyze phosphoglycerate mutase
enzymatic activity and may have significant structural or cata-
lytic roles (25, 27). In this context, we investigated phospho-
glycerate mutase activity in the absence or presence of increas-
ing concentrations of Mg2, Na, Li, and K, and as shown,
phosphoglyceratemutase activity was severely abrogated in the
absence of Mg2. However, Na, K, and Li did not signifi-
cantly modulate the enzymatic activity (supplemental Fig. S2C
and data not shown). Importantly, thesemetal ion properties of
the phosphoglycerate mutase domain of PE_PGRS11 are
shared in common with phosphoglycerate mutases reported
FIGURE 1. In silico analyses and functional characterization of multifunctional protein PE_PGRS11. A, i, the presence of the phosphoglycerate mutase
domain toward the C terminus of PE_PGRS11 protein upon the search against the domain database. Phosphoglyceratemutasematchedwith region 287–374
of PE_PGRS11 upon comparison with four Protein Data Bank structures, 1K6M, 1C81, 1TIP, and 1V7Q. All the active site residues of PE_PGRS11 (by active site
prediction methods) were identical with these templates. ii, a three-dimensional model of the PE_PGRS11 phosphoglycerate mutase domain constructed on
thebasis of template 1K6M. iii, representation of the active site residues of phosphoglyceratemutasewith 3-phosphoglyceric acid as a ligandupon automated
docking simulations with the AutoDock 3.0 software suite using Silicon Graphics station Octane. B, a typical hyperbolic substrate saturation plot for the
phosphoglycerate mutase enzyme activity of PE_PGRS11. The inset shows a Lineweaver-Burk plot to derive Km and the Vmax values for the phosphoglycerate
mutase enzyme activity of PE_PGRS11. C, quantitative real time RT-PCR analysis of PE_PGRS11 or HspX transcripts assessed in the RNA isolated from M.
tuberculosis grown under the indicated growth conditions. Error bars represent mean S.E. (n 3). The data represent three independent experiments.
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fromnematodes likeCaenorhabditis elegans andBrugiamalayi
and bacteria like Pseudomonas and Hyphomicrobium (25, 27).
In addition, we cloned and expressed the recombinant phos-
phoglycerate mutase domain of PE_PGRS11 to homogeneity.
The purified phosphoglycerate mutase domain of PE_PGRS11
also exhibited robust enzymatic properties similar to those of
full-length recombinant PE_PGRS11 protein (data not shown).
Mutational Analysis of Phosphoglycerate Mutase Domain of
PE_PGRS11—A sequence comparison between the phospho-
glyceratemutase domain of PE_PGRS11with four ProteinData
Bank structures including that of the crystal structure of phos-
phoglycerate mutase from Thermus thermophilus revealed
candidate residuesHis, Arg, and Ser for the catalytic triad of the
phosphoglycerate mutase domain of PE_PGRS11 (Fig. 1A).
Extensive published reports have utilized alanine as the substi-
tution residue of choice for mutational analysis because of its
small and mostly inert methyl functional group, which elimi-
nates the side chain beyond the  carbon but does not amend
the main chain conformation (28, 29). Importantly, amino acid
substitutionwith alanine does not impose extreme electrostatic
or steric effects, and alanine forms the basis for alanine scan-
ning, a commonly used technique to analyze the contribution of
specific residues to a given protein (30). In regard to our study,
critical catalytic residues at the active site of the phosphoglyc-
erate mutase domain of PE_PGRS11 are hydrophilic amino
acids. As predicted by secondary structure prediction, homol-
ogy domain modeling, and ligand docking studies, critical cat-
alytic residuesweremutated to alanine, thus adversely affecting
the enzyme function without altering the overall conformation
of the protein. In this perspective, different single mutants of
the phosphoglycerate mutase domain of PE_PGRS11, R289A,
H290A, and S348A; double mutant R289A,H290A; and triple
mutant R289A,H290A,G291A were generated. The recombi-
nantmutant proteinswere purified to homogeneity andhad the
samemolecular weight as the wild-type protein as evaluated by
similar mobilities on SDS-PAGE or immunoblot analysis (data
not shown). Furthermore, circular dichroism (CD) spectra of
mutant proteins did not demonstrate any significant conforma-
tional change (data not shown). As shown in supplemen-
tal Fig. S2D, all mutants failed to demonstrate any significant
phosphoglyceratemutase activity, and inclusion of a highmolar
excess of any of the mutant proteins failed to demonstrate any
significant activity as compared with wild-type PE_PGRS11
(data not shown).
Transcriptional Analysis Reveals That PE_PGRS11 Is a
Hypoxia-responsive Gene—Many reported observations sug-
gest that several members of the PE_PGRS family of antigens
respond to different environmental cues including hypoxia
(31). During latency,M. tuberculosis bacilli undergo a non-rep-
licating persistence state without compromising viability and
retain their ability to resume growth upon favorable conditions
(32). Similarly, M. tuberculosis, under an in vitro nutrient-de-
pleted stationary phase growth condition, exhibits a drastic
reduction of respiration rate, indicating a very low metabolic
rate or evenmetabolic inactivity. In addition, nutrient-depleted
stationary phase tubercle bacilli are reported to maintain full
viability, further suggesting functional similarity of the nutri-
ent-depleted growth environment with in vivo latent infection
conditions (33, 34). In this perspective, RNA was isolated from
mycobacteria grown to mid-log or stationary phase as well as
grown under hypoxic conditions, and PE_PGRS11 transcript
levels were assessed. For the hypoxia-related expression, theM.
tuberculosisH37Ra culture was subjected toWayne’s slow oxy-
gen depletionmodel, which is believed tomimic the conditions
of granulomas (16, 32). The analysis of PE_PGRS11 transcript
levels under different growth conditions was carried out by
quantitative RT-PCR as well as semiquantitative RT-PCR. The
data presented in Fig. 1C demonstrate that the expression level
of PE_PGRS11 was up-regulated in M. tuberculosis grown
under hypoxic conditions when compared with the RNA levels
inmycobacteria grown until mid-log phase. HspXwas used as a
positive control; it is known to be up-regulated inmycobacteria
under conditions like hypoxia as well as during infection (Fig.
1C). In addition, narG, known to have unaltered expression
during hypoxia and stationary phase, was utilized as a negative
control (supplemental Fig. S2E) (35). The differential expres-
sion at the transcript level in response to differential environ-
mental cues suggests that PE_PGRS11 might be regulated dif-
ferentially at the level of transcription under the above
mentioned conditions. In this perspective, primer extension
analysis of RNA of mycobacteria grown under mid-log phase,
hypoxia, or stationary phase was carried out. We observed that
the PE_PGRS11-specific primer extension product could be
detected only in the RNA isolated from M. tuberculosis sub-
jected to a hypoxic environment compared with stationary
phase, implicating PE_PGRS11 as a hypoxia-responsive gene
(data not shown).
Enforced Expression of PE_PGRS11 Imparts Resistance
against Oxidative Stress—Glycolytic enzymes are reported to
modulate cellular life spans by imparting resistance against oxi-
dative stress. Significantly, although phosphoglycerate mutase
overexpression resulted in an augmented rate of glycolysis and
escape from senescence, its depletionwas found to significantly
shorten the cellular lifespan (36, 37). In this perspective, reports
have suggested that theWarburg effect could contribute to eva-
sion mechanisms of cellular life span limitations imposed by
oxidative stress (38). Furthermore, deletion of phosphoglycer-
ate mutase in Bordetella bronchiseptica culminated in en-
hanced susceptibility to the superoxide radical-generating
chemical paraquat (39). Interestingly, the phosphoglycerate
mutasemutant exhibited susceptibility to antimicrobial pep-
tides and demonstrated decreased fitness in the mouse
typhoid model (40). To study the relative role of the phos-
phoglycerate mutase domain of PE_PGRS11, we examined
whether alveolar epithelial A549 cells, ectopically expressing
PE_PGRS11 antigen, were resistant to cellular life span
restrictions imposed by oxidative stress. For enforced expres-
sion, we generated recombinant replication-deficient adenovi-
rus expressing PE_PGRS11 (Ad-PE_PGRS11) or recombinant
M. smegmatis expressing PE_PGRS11 antigen. In all our exper-
iments where recombinant adenoviruses were utilized, a con-
trol adenovirus expressing -galactosidase (Ad-LacZ) was also
used. Infection of alveolar epithelial cells with Ad-PE_PGRS11
but not with Ad-LacZ protected them against hydrogen perox-
ide (H2O2)-induced cell death as analyzed by MTT viability
assay (Fig. 2A). The percent viability increased up to 4.5-fold in
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Ad-PE_PGRS11-infected alveolar epithelial cells in comparison
with respective Ad-LacZ-infected cells under oxidative stress
(Fig. 2A). However, enforced expression of another PE_PGRS
antigen, PE_PGRS17, by Ad-PE_PGRS17 failed to rescue cells
under oxidative stress, implicating a significant role for the
phosphoglycerate mutase domain of PE_PGRS11 (sup-
plemental Fig. S3A). For further validation, infection of alveolar
epithelial cells with recombinant M. smegmatis expressing
PE_PGRS11 demonstrated increased viability from 4-fold (25
M H2O2-treated cells) to 5.4-fold (50 M H2O2-treated cells)
comparedwith cells infectedwithM. smegmatis harboring vec-
tor control (Fig. 2B). Importantly, the recombinant phospho-
glycerate mutase domain of PE_PGRS11 also exhibited protec-
tive efficacy against H2O2-induced oxidative stress, quite
comparable with full-length recombinant PE_PGRS11 protein
(Fig. 2C). In addition, a triple mutant (Arg, His, and Ser) of the
catalytic triad of the phosphoglyceratemutase domain failed to
rescue the cells from H2O2-induced oxidative stress
(supplemental Fig. S3B). These observations clearly validate
a critical role for the phosphoglycerate mutase domain of
PE_PGRS11 in restricting the cellular lifespan forced by oxi-
dative stress.
PE_PGRS11-induced Activation of PI3K-ERK1/2-NF-B
SignalingAxis Requires TLR2Triggering at Cell Surface—Pattern
recognition receptors play a critical role in innate immunity,
and TLR, a known pattern recognition receptor, is involved in
recognition of pathogen-associatedmolecular patterns of path-
ogenic mycobacteria (41). Among
TLRs, TLR2 triggering by mycobac-
teria often culminates in secretion
of immunomodulatory cytokines
and initiation of immune responses
toMycobacterium bacilli by activat-
ing cascades of intracellular signal-
ing pathways (42–45). In the con-
text of a significant role for TLRs,
we investigated the ability of
PE_PGRS11 to bind TLR2 ex-
pressed on the cell surface of trans-
fected HEK-293 cells, and as shown
in Fig. 3A, confocal microscopic
studies suggest that PE_PGRS11
distinctively recognizes TLR2.
These results are in agreement with
our recent report wherein PE_P-
GRS11 specifically binds TLR2 and
induces maturation and activation
of human dendritic cells (46). TLR2
signaling in a variety of cellular sys-
tems often involves critical partici-
pation of the NF-B signaling path-
way. In this context, PE_PGRS11
binding to TLR2 triggered signifi-
cant NF-B promoter activity in
TLR2-transfected HEK-293 cells
compared with vector DNA-trans-
fected cells (Fig. 3B). This finding
was further evidenced by significant
translocation of p65 NF-B from the cytosol to the nucleus
within 30 min of stimulation with PE_PGRS11 (Fig. 3C). Inter-
estingly, the ability of PE_PGRS11 to trigger the NF-B activa-
tion was not compromised in macrophages derived from
TLR4-defective C3H/HeJ mice (data not shown), clearly impli-
cating the selective role for TLR2 in PE_PGRS-mediated signal-
ing events.
The activation of the NF-B pathway is often carefully
titrated by activation levels of PI3K or mitogen-activated pro-
tein kinase signaling in diverse cell types including alveolar epi-
thelial cells (47, 48). In mammalian cells, PI3K and ERK1/2
MAPK signaling pathways are widely acknowledged as key
mediators of cell survival (49, 50). These pathways play decisive
roles in controlling survival or apoptosis through the phosphor-
ylation of numerous cellular proteins as well as by articulating
the expression of an assortment of antiapoptotic genes includ-
ing Bcl2 (51). In this context, we investigated the potential role
of PE_PGRS11 antigen-TLR2-triggered activation of PI3K and
ERK1/2 during PE_PGRS11-induced survival of A549 cells.
Accordingly, PE_PGRS11 triggered activation of the PI3K or
ERK1/2 pathway as analyzed by phosphorylation of the p85
subunit of PI3K, 4EBP1, or ERK1/2 (Fig. 3D). These activation
events required the participation of TLR2 as the TLR2 domi-
nant-negative construct significantly reduced PE_PGRS11-
triggered activation of 4EBP1 and ERK1/2 (Fig. 3E). Further-
more, pharmacological intervention by specific inhibitor
LY294002 (PI3K) or AKT inhibitor I (AKT) abrogated
FIGURE 2. PE_PGRS11 imparts resistance to lung epithelial cells against oxidative stress. A, MTT assay to
determine cell viability ofA549cells infectedwithAd-PE_PGRS11orAd-LacZuponoxidative stress (25MH2O2
and 50 M H2O2). B, determination of cell viability of A549 cells infected with recombinant M. smegmatis
pJAM2-PE_PGRS11 orM. smegmatis pJAM2 vector alone after 48 h of oxidative stress (25 M H2O2 and 50 M
H2O2). C, percent cell viability for A549 cells under oxidative stress (50 M H2O2) upon treatment with recom-
binant wild-type PE_PGRS11 (WT PE_PGRS11) or the phosphoglycerate mutase domain of PE_PGRS11 (PGM).
Error bars represent mean S.D. The data are representative of three independent experiments. MOI, multi-
plicity of infection.
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PE_PGRS11-induced activation of ERK1/2, alluding to a sig-
nificant role for the TLR2-PI3K signaling axis in ERK1/2
activation (Fig. 3F). These results suggest that the NF-B,
PI3K, and ERK1/2 pathways characterize important key
molecular links during PE_PGRS11-induced signaling cas-
cades in host cells.
PE_PGRS11-induced Resistance to Oxidative Stress Necessi-
tates Modulation of Specific Antiapoptotic Molecular Sig-
natures—Crucial cell fate decisions adapt to diverse environ-
mental perturbations like oxidative stress by reorganizing their
signaling networks with concomitant expression of antiapop-
totic genes, all of which could represent a significant host
response. In this regard, expression of COX-2 and Bcl2 is often
correlated with the survival of cells during oxidative stress (52,
53). COX-2 regulates p53 activation and inhibits p53- or geno-
toxic stress-induced apoptosis directly through close interac-
tion between two molecules in a variety of cell types (52). In
addition, PGE2, a product of COX-2 enzymatic activity, has
been shown to modulate apoptosis and induce expression of
Bcl2 in various cell types, suggesting a crucial role for COX-2 in
the regulation of apoptosis (54). Bcl2, an important member of
the Bcl family, is critical for regulation of apoptosis across
diverse cell types. Bcl2 acts along the intrinsic mitochondrial
apoptosis pathway that is activated in response to a number of
stress stimuli including oxidative stress (53). In view of the
above mentioned observations, we assessed the ability of
PE_PGRS11 to trigger TLR2-mediated COX-2 or Bcl2 expres-
sion. As demonstrated, PE_PGRS11 induced the expression of
COX-2, its activity product PGE2, or Bcl2 in a dose-dependent
manner (Fig. 4A and data not shown). Interestingly, although
PGE2 augmented the Bcl2 expression, inhibition of COX-2
activity markedly reduced PE_PGRS11-induced Bcl2 expres-
sion, evidently implicating the COX-2-driven signaling events
in Bcl2 expression (Fig. 4, B and C). The expression of Bcl2 or
COX-2 is reported to involve activation as well as extensive
cross-talk between PI3K and mitogen-activated protein kinase
pathways. Accordingly, signaling perturbation of PI3K or
ERK1/2 by pharmacological inhibitors abrogated PE_PGRS11-
driven COX-2 and Bcl2 expression (Fig. 4D and data not
shown).
FIGURE3.PE_PGRS11 triggersTLR2-dependentactivationofPI3K-ERK1/2-NF-Bsignalingaxis.A, TLR2- or vector-transfectedHEK-293 cellswere treated
with PE_PGRS11. The cells were further stained with antibody specific to PE_PGRS11 followed by Cy5-labeled secondary antibody. The immunofluorescence
staining of cells was analyzed by confocal microscopy. B, HEK-293 cells, transiently transfected with vector or TLR2 cDNA construct along with NF-B reporter
construct,were treatedwithdifferentdosesof PE_PGRS11protein followedbyanalysis ofNF-B reporter activity (meanS.E.,n3).C, A549 cellswere treated
with PE_PGRS11 protein for the indicated time points followed by immunoblotting of nuclear and cytosolic fractions of cells for NF-B. D, activation of p85
(PI3K), ERK1/2, and 4EBP1 by PE_PGRS11. E, transfection of cells with TLR2 dominant-negative (D/N) cDNA construct abrogates PE_PGRS11-induced activation
of ERK1/2 and 4EBP1. F, A549 cells were pretreatedwith LY294002 or AKT inhibitor (Inhi.) followed by analysis of PE_PGRS11-induced activation of ERK1/2. The
results are representative of two independent experiments. PCNA, proliferating cell nuclear antigen; p, phospho;Med, medium.
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As described, COX-2 and Bcl2 act as important effector
molecules for cell survival under oxidative stress, and in this
context, a member of the mitogen-activated protein kinase
family, p38, is suggested to be preferentially activated by
oxidative stress. p38 is the archetypal member of the second
MAPK-related pathway, and a number of findings indicate
that the activation of p38 may play decisive roles in the con-
trol of cell death. In the case of PC-12 neuronal cells or
NIH-3T3 fibroblasts, interference with p38 kinase activation
significantly abrogated apoptosis by nerve growth factor
deprivation or UV irradiation (49, 55, 56). Critically, oxida-
tive stress-induced apoptosis in a variety of cellular systems
is suggested to involve activation of p38 MAPK (57). As
shown, enforced expression of PE_PGRS11 in alveolar epi-
thelial A549 cells imparted resistance to H2O2-induced oxi-
dative stress (Fig. 2). In this context, exposure of alveolar
epithelial cells to H2O2 resulted in the activation of p38
MAPK (Fig. 4E). Importantly, PE_PGRS11-triggered TLR2
signaling events abrogated oxidative stress-induced activa-
tion of p38 MAPK (Fig. 4F).
Furthermore, we evaluated the role of the phosphoglycerate
mutase domain in PE_PGRS11-induced signaling events in
alveolar epithelial A549 cells. Recombinant phosphoglycerate
mutase of PE_PGRS11 effectively triggered the activation of the
PI3K, ERK1/2, or NF-B signaling pathway as analyzed by
phosphorylation of the p85 subunit of PI3K, 4EBP1, or ERK1/2
and translocation of p65 NF-B from the cytosol to the nucleus
(supplemental Fig. S4, A and B). These observations are quite
comparable with PI3K-ERK1/2-NF-B signaling activation
observed with full-length recombinant PE_PGRS11 protein. In
concordance to results obtained with full-length recombinant
PE_PGRS11 protein, the phosphoglycerate mutase domain
alone induced the expression of COX-2 and Bcl2 as well as
abrogated the oxidative stress-induced activation of p38MAPK
(supplemental Fig. S4, C and D). Taken together, TLR2-depen-
dent expression of COX-2 and Bcl2 and abrogation of H2O2-
induced p38 kinase activation by
PE_PGRS11 clearly provide amech-
anistic basis for the rescue of lung
epithelial cells from oxidative stress.
Critical Role of PE_PGRS11 in
Survival of Mycobacteria under
Oxidative Stress—Many reports
have suggested that PE_PGRS anti-
gens localize to the cell wall by the
PE domain anchoring the protein to
the cell wall, thus allowing the anti-
genically variable PGRS domain to
gain access to extracellular com-
partments from infected macro-
phages (10, 12, 13). To examine
the subcellular localization of the
PE_PGRS11, a recombinant M.
smegmatis strain expressing PE_P-
GRS11 was subjected to cell frac-
tionation studies and analyzed by
immunoblotting using anti-PE_P-
GRS11 antibodies. Analysis of the
cellular fractions of recombinant M. smegmatis demonstrated
that the majority of PE_PGRS11 protein could be detected in
the insoluble fraction of the cell preparation, and little if any
PE_PGRS11 protein was detected in the soluble fraction (Fig.
5A). Furthermore, PE_PGRS11 could be detected only in the
cell wall fraction but not in cytosol fractions derived from M.
tuberculosis H37Rv (Fig. 5A). Assessment of the purity of cell
wall fractions in terms of cytosolic contamination was carried
out by probing the cellular fractions with monoclonal antibod-
ies reactive to cytosolic catalase-peroxidase KatG of M. tuber-
culosis. Accordingly, although the cell wall fraction did not dis-
play any presence of KatG, cytosolic fractions exhibited
reactivities to antibodies against KatG, thereby validating the
purity of the cell wall preparations (data not shown). To inves-
tigate whether PE_PGRS11 is exposed on the mycobacterial
surface, M. smegmatis overexpressing PE_PGRS11 was sub-
jected to proteinase K and trypsin sensitivity assays. Proteinase
K and trypsin sensitivity assays have been widely used to study
the cell surface localization of bacterial proteins (58, 59). Data
shown in Fig. 5B demonstrate that PE_PGRS11 was efficiently
digested by the proteinase K treatment with complete digestion
after 5min. A comparable pattern was obtained whenM. smeg-
matis expressing PE_PGRS11 was subjected to trypsin diges-
tion and analyzed by immunoblotting (Fig. 5B). These observa-
tions corroborate that PE_PGRS11 protein is exposed at the
mycobacterial cell surface and might gain access to the extra-
cellular environment.
The “respiratory burst” of invading host cells caused by
reactive oxygen species represents one of the significant host
effector functions in response to an infection. For example,
H2O2 reacts with reduced copper or iron ions in the cyto-
plasm of bacteria, leading to generation of free hydroxyl rad-
icals, which in turn culminates in single strand nicks in DNA
and oxidation of proteins as well as biological membranes
(60, 61). Interestingly, many bacteria including M. tubercu-
losis detoxify reactive oxygen species, thus providing the
FIGURE4.PE_PGRS11 induced rescue fromoxidative stress: activationof antiapoptotic and inhibitionof
apoptotic signalingaxis.A, inducedexpressionof COX-2 andBcl2 uponPE_PGRS11 treatment as analyzedby
immunoblotting. B, dose-dependent increase in Bcl2 expression upon PGE2 treatment. C, A549 cells were
pretreated with NS-398, and PE_PGRS11-induced Bcl2 expression was analyzed by immunoblotting. D, pre-
treatment of A549 cells with U0126 and LY294002 leads to abrogation of PE_PGRS11-induced COX-2 expres-
sion. E, activation of p38 MAPK upon exposure of cells to H2O2. F, PE_PGRS11 abolishes H2O2-mediated acti-
vation of p38 MAPK. The blots are representative of three independent experiments. p, phospho; Med,
medium.
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predominant challenge to its eradication by robust host
immunity (62, 63). In this perspective, observations shown in
Fig. 2 clearly suggest a protective role for PE_PGRS11 in
providing resistance to epithelial cells against H2O2-trig-
gered oxidative stress. Because a number of microbial cell
surface proteins have been suggested to have a moonlighting
property of protecting the bacteria against host-induced
stress responses, we decided to investigate the potential role,
if any, for PE_PGRS11 in executing resistance to mycobac-
teria against oxidative stress. In this regard, sensitivity assays
with H2O2 were carried, and as shown, recombinant M.
smegmatis overexpressing PE_PGRS11 exhibited significant
proliferation under oxidative stress compared with vector-
transformedM. smegmatis (Fig. 5C). For further validation, a
well validated andmore conclusive “zone of inhibition assay”
was carried out wherein bacteria are plated uniformly on a
culture plate followed by placement of a filter paper disk
permeated with the compound to be tested (64). Accord-
ingly, when tested against oxidative stress inducer H2O2, the
size of the zone of clearance was significantly smaller in the
case of recombinant M. smegmatis expressing PE_PGRS11
compared with M. smegmatis harboring vector, thus ascer-
taining a potential role for PE_PGRS11 in providing resis-
tance to bacteria against oxidative stress (Fig. 5D).
Overexpression of PE_PGRS11 Contributes to Alterations in
Colony Morphology—The characteristic lipid-rich cell wall is a
critical attribute of Mycobacterium species, and each cell wall
component plays a significant role in phenotypic features
including colony morphology, resistance to various environ-
mental stresses, virulence, etc. Furthermore, changes in colony
morphology within a given species ofMycobacterium can have
differential effects on the signaling events initiated in infected
cells, resulting in a degree of difference in virulence as well as in
mycobacterial survival (65–67). For example, among an iso-
genic pair ofMycobacterium aviummorphotypes, whereas the
virulent smooth transparent (SmT)morphotype proliferated in
murinemacrophages in a p38mitogen-activated protein kinase
activation-dependent manner, proliferation of the less virulent
smooth opaque (SmO) morphotype to some extent was
dependent upon ERK1/2 activation (68, 69). These studies
clearly recognized the roles for phenotypic changes of the
mycobacteria in virulence. In view of the above, we assessed the
FIGURE 5. Subcellular localization and role of PE_PGRS11 in protection of mycobacteria against oxidative stress. A, i, recombinant M. smegmatis
expressing PE_PGRS11 under an acetamide-inducible promoter was constructed, and different cellular fractions of M. smegmatis transformed with either
pJAM2 or pJAM2-PE_PGRS11 were immunoblotted with antiserum to PE_PGRS11. Lane 1, cell wall fraction of inducedM. smegmatis (pJAM2); lane 2, cytosol
fraction of inducedM. smegmatis (pJAM2); lane 3, cell membrane fractions of inducedM. smegmatis (pJAM2); lane 4, cell wall fraction of inducedM. smegmatis
(pJAM2-PE_PGRS11); lane 5, cytosol fraction of inducedM. smegmatis (pJAM2-PE_PGRS11); lane 6, cell membrane fraction of inducedM. smegmatis (pJAM2-
PE_PGRS11); lane 7, purified PE_PGRS11 protein. ii, expression of PE_PGRS11 was analyzed by immunoblotting in various cellular fractions ofM. tuberculosis
H37Rv cells. Lane 1, whole cell lysate ofM. tuberculosis; lane 2, cell wall fraction ofM. tuberculosis; lane 3, culture filtrate proteins ofM. tuberculosis; lane 4, cytosol
fraction of M. tuberculosis; lane 5, purified PE_PGRS11 protein. B, M. smegmatis transformed with pJAM2 or pJAM2-PE_PGRS11 were subjected to partial
digestion by either proteinase K or trypsin for the indicated time points, and cell lysates were analyzed for integrity of PE_PGRS11 by immunoblotting.
C, growthand survival ofM. smegmatis transformedwithpJAM2orpJAM2-PE_PGRS11 in thepresenceof oxidative stress (5mMhydrogenperoxide).D, analysis
of zone of inhibition forM. smegmatis transformed with pJAM2 or pJAM2-PE_PGRS11 upon oxidative stress (30% H2O2) (mean S.E., n 3). E, micrographs
representing colony morphology ofM. smegmatis transformed with pJAM2 or pJAM2-PE_PGRS11. F, electron micrographs ofM. bovis BCG transformed with
pMV361 sense PE_PGRS11 (M. bovis BCG S-PE_PGRS11) or pMV361 antisense PE_PGRS11 (M. bovis BCG AS-PE_PGRS11). The data represent two independent
experiments.
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effects of overexpression of PE_PGRS11 on the colony mor-
phology of recombinantM. smegmatis, and as demonstrated in
Fig. 5E, ectopic expression of PE_PGRS11 resulted in the rough,
glossy, bigger, strongly cohesive phenotype of colonymorphol-
ogy variants in comparison with the small, smooth, translucent
phenotype of the vector-transformed counterpart. This obser-
vation in our opinion suggests a role for variation in colony
morphology in adaptation of bacteria to resist stress conditions.
For further validation,M. bovis BCG expressing reduced lev-
els of PE_PGRS11 protein was constructed by antisense RNA,
and the expression levels of PE_PGRS11 were determined by
immunoblotting. The sense and control transformants exhib-
ited stronger and weaker reactivity, respectively, whereas no
corresponding distinct band was observed in the antisense
transformant (data not shown). To ascertain the expression of
PE_PGRS11 with altered colony morphology, we analyzed the
morphology of sense or antisense transformants by scanning
electron microscopy. Data represented in Fig. 5F clearly show
that antisense PE_PGRS11 transformants of M. bovis BCG
exhibited a smooth, translucent phenotype in accordance
with results obtained with M. smegmatis overexpressing
PE_PGRS11. Taken together, these observations suggest a
strong correlation of expression of PE_PGRS11 to the pheno-
typic changes in mycobacteria, which could result in the aug-
mented ability to resist the hostile oxidative stress environment
of the host cells.
Recombinant PE_PGRS11 Displays Differential B Cell
Responses during Tuberculosis Infection—Our results have sub-
stantiated that PE_PGRS11 protein is exposed at the mycobac-
terial cell surface and might gain access to the extracellular
compartments from infected host cells, suggesting accessibility
of PE_PGRS11 to the immune system of the infected host. As
described, PE_PGRS11 is reported
to play a critical role in the patho-
genesis of tuberculosis and in the
host innate and adaptive immune
responses to bacilli (8, 9). Further-
more, we have recently demon-
strated that PE_PGRS11 recognizes
TLR2, induces maturation and acti-
vation of human dendritic cells, and
enhances the ability of dendritic
cells to stimulate CD4 T cells (46).
In this regard, we evaluated the role
of PE_PGRS11 as an antigen in a
clinical setting. Experiments were
designed to evaluate the potential
humoral immune responses in sera
from different clinical categories of
tuberculosis patients to purified
PE_PGRS11 protein. Recombinant
protein was utilized to screen TB
patient sera or CSF by ELISA, utiliz-
ing anti-human IgG-HRP and anti-
human IgM-HRP antibodies as con-
jugates. As shown in Fig. 6A, sera
from group 1 adult patients diag-
nosed with pulmonary TBmounted
significantly higher IgG antibody responses against PE_P-
GRS11 than sera from healthy controls. Furthermore, similar
results were observed in the case of group 1 child patients (Fig.
6B). However, PE_PGRS11 did not demonstrate statistically
significant reactivity to IgG in sera from adult patients with
relapsed infection in group 2 (Fig. 6A). The sera from group 2
child patients were not available for our studies. In the case of
group 3 patients reporting extrapulmonary infections, only
children but not adults elicited significant IgG immunoreactiv-
ity (Fig. 6,A andB).When analyzed for IgM antibody responses
against PE_PGRS11, sera from adult patients of groups 1, 2, and
3 demonstrated stronger immunoreactivity in comparisonwith
healthy controls (Fig. 6C). In contrast, PE_PGRS11 did not
demonstrate any significant reactivity to IgM in sera from child
patients from groups 1 and 3 (Fig. 6D). Asmentioned, sera from
child group 2 patients were not available for study.
We have shown previously that two PE_PGRS antigens dem-
onstrated differential reactivities of the humoral antibodies,
clearly suggesting a degree of difference in recognition by
patient sera even though they share a similarN- andC-terminal
region (7). In this regard, when analyzed, individual patients
(group 1 adult and child) demonstrated differential humoral
reactivity to PE_PGRS11 and PE_PGRS33, suggesting specific-
ity of the humoral immune response against PE_PGRS11
(supplemental Fig. S5).
As a step further, we investigated the immunoreactivity
potential of PE_PGRS11 in CSF of patients with TBM, a clinical
case of extrapulmonary tuberculosis infection. As demon-
strated in Fig. 6E, PE_PGRS11 exhibited statistically significant
IgG antibody reactivities in CSF samples derived from TBM
patients. Interestingly, the reactivity of PE_PGRS11 was similar
to that of M. tuberculosis H37Rv whole cell lysate (Fig. 6E).
FIGURE 6. Differential immunoreactivity of PE_PGRS11 protein with sera or CSF from different catego-
ries of TB patients. A and B, PE_PGRS11 protein showed significant reactivity in all the groups in child TB
patients for IgG antibody (B), whereas adult patients showed no reactivity except group 1 patients (A). C andD,
whenassessed for IgMantibody, PE_PGRS11 showed significant reactivity in all the categories of adult patients
(C) but not in the case of any group of child TB patients (D). E, the IgG antibody reactivity to M. tuberculosis
H37Rv whole cell lysate (WCL) and PE_PGRS11 in CSF from TBM patients in comparison with healthy controls
and other meningitis disease controls. Gr 1, pulmonary infection; Gr 2, relapsed infection; Gr 3, extrasputum
infection; HC, healthy control; ODC, other disease control.
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However, neither PE_PGRS11 nor H37Rv whole cell lysate
showed any significant reactivity to CSF samples from healthy
controls or other disease controls. Furthermore, PE_PGRS11
exhibited a very high antigenic index for the potential antigenic
determinants (data not shown), and our recent study has sug-
gested that patients with pulmonary tuberculosis disease have a
high frequency of T cells specific for PE_PGRS11 that secrete
IFN- and IL-5 in response to PE_PGRS11 antigen stimulation
(46). Additionally, DNA immunization experiments suggested
that PE_PGRS11 could elicit robust T cell responses in vivo in
mice (data not shown). Taken together, these results demon-
strate that PE_PGRS11could be an immunodominant antigen
expressed in vivo during infection and possesses probable sero-
diagnostic potential.
DISCUSSION
Diverse biological systems frequently modulate and reorga-
nize intracellular physiological and metabolic pathways, repre-
senting important adaptive responses. Different stresses such
as oxidative stress often result in both conserved and specific
responses from the host cells, and in this context, pathogenic
microbes have utilized these adaptive responses for their own
survival amid robust host immune responses (62, 63). In the
current study, we describe the functional attributes of a
novel, unannotated cell wall-associated PE_PGRS antigen,
PE_PGRS11, encoded by theM. tuberculosis genome.We dem-
onstrate here that hypothetical PE_PGRS11 ORF encodes a
functional phosphoglycerate mutase, and bioinformatics pre-
diction of the phosphoglycerate mutase domain identified His,
Arg, and Ser as the critical residues of the catalytic triad. In this
regard, the catalytic properties of the phosphoglycerate mutase
domain of PE_PGRS11 were quite similar to those of phospho-
glycerate mutase from various biological systems (25–27).
Importantly, mutation of any of the three residues of the cata-
lytic triad abrogated the phosphoglycerate mutase activity of
PE_PGRS11. As described, the PE_PGRS subfamily of PE genes
is suggested to act as virulence factors because of their unique
restriction as genes with a high probability of being essential in
M. tuberculosis survival in the host (5, 10, 11, 70). Studies have
reported that several PE_PGRS family antigens respond to dif-
ferent environmental cues including hypoxia, and in vivo selec-
tive expression of specific PE_PGRS antigens could be the con-
tributory reason for the various pathological attributes of M.
tuberculosis (8–11). The expression profiling investigations
have revealed that PE_PGRS11 is selectively expressed in M.
tuberculosis bacilli upon infection ofmacrophages and could be
detected in lung tissues of infected mice (8, 9). Furthermore,
our transcriptional analysis demonstrated that PE_PGRS11 is a
hypoxia-responsive gene similar to HspX.
Across many cellular systems, a strong correlation between
glycolytic enzymes, reactive oxygen species, and cell prolifera-
tion has been documented. Glycolytic enzymes are reported to
modulate cellular life spans by eliciting protection from oxida-
tive stress (36–38). For example, the highly active glycolytic
metabolic pathway in embryonic stem cells contributes to
immortality despite a strong p53 expression induced upon
DNA damage (38). In this context, phosphoglycerate mutase
has been demonstrated to increase the rate of glycolysis,
decrease the accumulation of reactive oxygen species, and
bypass senescence in mouse embryo fibroblasts (38). In addi-
tion, exposure of lung fibroblasts to hypoxia resulted in the
induction of phosphoglycerate mutase enzymatic activity with
concomitant elevations in phosphoglycerate mutase mRNA
and protein levels. Induction of phosphoglycerate mutase con-
tributed to the regulation of the glycolytic flux under hypoxic
conditions and demonstrated its role in the adaptation of cells
to hypoxia (71). Furthermore, a phosphoglycerate mutase-null
mutant of B. bronchiseptica showed enhanced susceptibility to
the superoxide radical as well as to antimicrobial peptides with
concomitant decreased fitness in themouse typhoidmodel (39,
40). In this context, we explored whether enforced expression
of PE_PGRS11 imparts resistance against oxidative stress in
alveolar epithelial cells. Alveolar epithelial cells in addition to
alveolar macrophages act as first responders in a diverse set
of infections including that of pathogenic mycobacteria and
play a significant role in initiation as well as control of the
magnitude of host immunity (72–74). As demonstrated, the
ectopic expression of PE_PGRS11 in alveolar epithelial cells
via recombinant adenovirus or recombinant M. smegmatis
imparted resistance to H2O2-triggered oxidative stress. This
observation is thus attributed to the phosphoglycerate
mutase domain of PE_PGRS11, which is in accordance with
reported studies describing a role for phosphoglycerate
mutase in evading cellular life span restrictions mediated by
oxidative stress.
We have recently demonstrated that PE_PGRS11 antigen
triggers maturation of dendritic cells as exemplified by up-reg-
ulation of costimulatory and antigen-presentingmolecules and
increased production of proinflammatory cytokines. Further-
more, PE_PGRS11 induced CD4 T cell proliferation and secre-
tion of cytokines in vitro and in vivo fromTcells in patientswith
pulmonary tuberculosis (46). Here we show that PE_PGRS11
protein recognized TLR2 on alveolar epithelial cells and
induced activation of PI3K, ERK1/2, andNF-B pathways, thus
representing important signaling partnership integration in
host cells. This signaling cross-talk, induced by PE_PGRS11
antigen, culminated in the induction of the expression of
COX-2, its activity product PGE2, andBcl2 in a dose-dependent
manner. Furthermore, PE_PGRS11 antigen treatment abol-
ishedH2O2-triggered activation of p38MAPK,which is amajor
kinase involved in stress-induced apoptosis in various cell
types. Importantly, PE_PGRS11 protein was exposed at the
mycobacterial cell surface and executed resistance tomycobac-
teria against oxidative stress. Interestingly, overexpression of
PE_PGRS11 contributed to alterations in colony morphology,
and in our opinion, this variation in colony morphology could
be an adaptation of bacteria to resist stress conditions. Further-
more, PE_PGRS11 exhibited immunoreactivity to sera from
adult patients with pulmonary tuberculosis and child patients
with pulmonary or extrapulmonary infection. The observed
humoral immune response against a hypoxia-responsive gene
(PE_PGRS11) in patients with active tuberculosis disease is
interesting. As reported earlier, many hypoxia-specific myco-
bacterial antigens like Rv1168c, Rv1169c, Rv2430c, and others
have been demonstrated to elicit robust humoral/antibody
reactivities in patients with active pulmonary tuberculosis dis-
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ease (with active lesions) (7, 75, 76). Interestingly, PE_PGRS62
elicited strong antibody responses in patients with latent infec-
tion as well as in patients with active pulmonary tuberculosis
disease (77). These observations suggest that the expression
levels of these antigens including PE_PGRS11 upon reaching a
certain threshold level during hypoxic or other stages of infec-
tion could trigger amultitude of host immune responses, which
could be sustained in terms of strength as well as magnitude
during the life span of the infected individuals. Overall, these
observations suggest that PE_PGRS11 is expressed in vivo dur-
ing disease pathogenesis and could significantly contribute to
immune evasion strategies of pathogenic mycobacteria against
oxidative stress.
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Supplementary Figure S1. The primer pairs used to mutate specific active site residues in 
Phosphoglycerate mutase domain of PE_PGRS11. 
 
 
 
 
 
 
 
 
 
 
 
 2 
 
 
Supplementary Figure S2. Analysis of kinetic parameter associated with Phosphoglycerate 
mutase enzyme activity of PE_PGRS11. A. The SDS-PAGE gel representing the expression and 
purification of PE_PGRS11. Lane 1, uninduced E. coli; lane 2, induced E. coli; lane 3, protein marker; 
lane 4, eluted PE_PGRS11 protein. B. The graph representing pH optimum for Phosphoglycerate mutase 
enzyme activity of PE_PGRS11. Enzyme activity was measured in pH range of 6–11 in different buffers 
(pH 6.0–7.0, imidazole buffer; pH 8.0–9.0, Tris–HCl buffer; pH 10.0–11.0, Sodium acetate buffer) using 
1 μg purified PE_PGRS11 protein in the reaction mix at 25º C. C. Effect of Mg++ on Phosphoglycerate 
mutase enzyme activity. Enzymatic reactions were carried out in presence or absence of Mg++ (essential 
co-ion required for Phosphoglycerate mutase activity of PE_PGRS11) for indicated time points. The 
importance of Mg++ was further established by using EDTA as a chelating agent in 1:1 ratio to chelate out 
Mg++. D. Active site mutants of PE_PGRS11 ‘s Phosphoglycerate mutase domain (R289A; H290A; 
S348A; R289A, H290A; R289A, H290A, G291A)  exhibited significant reduction in the catalytic 
properties of the protein. E .Expression analysis of narG transcripts in the RNA isolated from M. 
tuberculosis grown under indicated growth conditions. The results are representative of three independent 
experiments. WT, Wild type 
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Supplementary Figure S3. Specificity and role of Phosphoglycerate mutase domain of 
PE_PGRS11 in protection of alveolar epithelial A549 cells against oxidative stress. A. PE_PGRS17 does 
not protect lung epithelial cells against oxidative stress.  Cell viability of A549 cells infected with Ad-
PE_PGRS17 or Ad-LacZ upon oxidative stress (25μM H2O2) as determined by MTT assay. B. Percentage 
cell viability for A549 cells under oxidative stress (50μM H2O2) upon treatment with triple mutant 
R289A, H290A, G291A of PE_PGRS11 (PE_PGRSRHG). The data represent two independent 
experiments. 
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Supplementary Figure S4. Phosphoglycerate mutase (PGM) domain of PE_PGRS11 regulates 
apoptotic and anti-apoptotic signaling axis in alveolar epithelial A549 cells. A. Phosphoglycerate mutase 
(PGM) domain triggers activation of p85 (PI3K), ERK1/2 and 4EBP1. B. Phosphoglycerate mutase 
(PGM) domain induced nuclear translocation of NF-κB. C. Induced expression of COX-2 and Bcl2 by 
Phosphoglycerate mutase (PGM) domain. D. Phosphoglycerate mutase (PGM) domain inhibits H2O2 
triggered activation of p38 MAPK. The blots are representative of two independent experiments.  
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Supplementary Figure S5. Individual pulmonary tuberculosis patients demonstrate differential 
antibody responses to PE_PGRS11 and PE_PGRS33. A & B. Differential humoral antibody responses to 
PE_PGRS11 and PE_PGRS33 from sera of selected (A) adult and (B) child pulmonary tuberculosis 
patients (group 1).  
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